Acquisition by Gerhard Lombard of 900 shares of Crescent Capital at 16.89 subject to Rule 16b-3
| CCAP Stock | USD 19.60 0.26 1.34% |
Slightly above 52% of Crescent Capital's retail investors are presently thinking to get in. The analysis of overall sentiment of trading Crescent Capital BDC stock suggests that some investors are interested at this time. Crescent Capital's investing sentiment overview a quick insight into current market opportunities from investing in Crescent Capital BDC. Many technical investors use Crescent Capital BDC stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Crescent |
Filed transaction by Crescent Capital BDC Officer: Chief Financial Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at news.google.com
 |
Crescent Capital Fundamental Analysis
We analyze Crescent Capital's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Crescent Capital using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Crescent Capital based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Per Share
Cash Per Share Comparative Analysis
Crescent Capital is currently under evaluation in cash per share category among its peers. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Crescent Capital BDC Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Crescent Capital stock to make a market-neutral strategy. Peer analysis of Crescent Capital could also be used in its relative valuation, which is a method of valuing Crescent Capital by comparing valuation metrics with similar companies.
Peers
Crescent Capital Related Equities
| MRCC | Monroe Capital | 1.32 | ||||
| TSLX | Sixth Street | 1.22 | ||||
| WHF | WhiteHorse Finance | 1.22 | ||||
| PTMN | Portman Ridge | 1.10 | ||||
| TCPC | BlackRock TCP | 1.02 | ||||
| CGBD | Carlyle Secured | 0.49 | ||||
| GBDC | Golub Capital | 0.46 | ||||
| DHIL | Diamond Hill | 0.46 | ||||
| NMFC | New Mountain | 0.45 | ||||
| FDUS | Fidus Investment | 0.37 | ||||
| TPVG | Triplepoint Venture | 1.55 |
Additional Tools for Crescent Stock Analysis
When running Crescent Capital's price analysis, check to measure Crescent Capital's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Crescent Capital is operating at the current time. Most of Crescent Capital's value examination focuses on studying past and present price action to predict the probability of Crescent Capital's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Crescent Capital's price. Additionally, you may evaluate how the addition of Crescent Capital to your portfolios can decrease your overall portfolio volatility.